First Wave BioPharma Inc Files For Shelf Of Up To 3.4M Shares Of Common Stock By Selling Stockholders
Portfolio Pulse from Benzinga Newsdesk
First Wave BioPharma Inc has filed for a shelf offering of up to 3.4 million shares of common stock by selling stockholders, according to an SEC filing.

June 20, 2023 | 8:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
First Wave BioPharma's filing for a shelf offering of up to 3.4 million shares may lead to short-term stock price fluctuations.
The shelf offering of up to 3.4 million shares by selling stockholders may cause short-term fluctuations in FWBI's stock price due to the potential increase in supply. However, the long-term impact is uncertain as it depends on the market's reaction and the company's performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100